Entera Bio Ltd. (ENTX) vs NRx Pharmaceuticals, Inc. (NRXP)
A side-by-side comparison of Entera Bio Ltd. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.57HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
NRXP
NRx Pharmaceuticals, Inc.
$2.90HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ENTX vs NRXP
growth of $100 · dividends reinvested · last 8yENTX -58.3% (-10.4%/yr)NRXP -97.1% (-35.8%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
ENTX NRXP
ENTX vs NRXP: by the numbers
- •ENTX is the larger company ($126M vs $126M market cap).
- •Both run net losses; NRXP's is the smaller (-691.81% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | NRXP |
|---|---|---|
| P/S ratio | N/A | 36.99 |
| P/B ratio | 17.40 | N/A |
Profitability
| Metric | ENTX | NRXP |
|---|---|---|
| Gross margin | 0.00% | 58.78% |
| Operating margin | -27450.00% | -1324.41% |
| Net margin | -27235.71% | -691.81% |
| ROE | -234.42% | N/A |
| ROIC | -82.87% | N/A |
Growth (annualized)
| Metric | ENTX | NRXP |
|---|---|---|
| Total return CAGR (5Y) | -10.57% | -49.61% |
Frequently asked
- How have ENTX and NRXP total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.